Marco de Bruyn

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell et al. · Journal of Clinical Oncology · 2020 · 837 citations · Full text

Medicine, Molecular Medicine, Oncology +17

cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers

Christy Hong, Michaël Schubert, Andréa E. Tijhuis et al. · Nature · 2022 · 363 citations · Full text

Medicine, Immunology, Oncology +14

<i>POLE</i> Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

Inge C. van Gool, Florine A. Eggink, Luke Freeman-Mills et al. · Clinical Cancer Research · 2015 · 318 citations · Full text

Medicine, Immunology, Oncology +17

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer

Hagma H. Workel, Joyce M. Lubbers, Roland Arnold et al. · Cancer Immunology Research · 2019 · 262 citations · Full text

Life Sciences, Immunology, Oncology +17

MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells

Thijs S Stutvoet, Arjan Kol, Elisabeth G.E. de Vries et al. · The Journal of Pathology · 2019 · 165 citations · Full text

Medicine, Oncology, Pharmacology +17